Ginkgo Bioworks (DNA) 8-K Regulation FD Disclosure

Exhibit 99.1

SOARING EAGLE ACQUISITION CORP.

BALANCE SHEET

	February 26, 2021			Pro Forma Adjustments			As Adjusted
	(As filed)			(Unaudited)			(Unaudited)
ASSETS:
Current asset:
Cash	$	3,000,000		$	—		$	3,000,000
Total current assets		3,000,000			—			3,000,000
Cash held in Trust Account		1,725,000,000			—			1,725,000,000
Total assets	$	1,728,000,000		$	—		$	1,728,000,000
LIABILITIES AND SHAREHOLDER’S EQUITY:
Current liabilities:
Accounts payable and accrued offering costs	$	784,260		$	—		$	784,260
Promissory Note - Related Party		300,000			—			300,000
Advance from Sponsor		156,333			—			156,333
Total current liabilities		1,240,593			—			1,240,593
Derivative warrant liabilities		—			107,692,500			107,692,500
Deferred underwriting compensation		60,375,000			—			60,375,000
Total liabilities		61,615,593			107,692,500			156,600,593
Class A ordinary shares subject to possible redemptions; 166,138,440 and 155,369,190 shares at $10 per share, actual and adjusted, respectively		1,661,384,400			(107,692,500	)		1,553,691,900
Commitments and contingencies
Shareholders’ equity:
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding		—			—			—
Class A ordinary shares, $0.0001 par value; 400,000,000 shares authorized; 6,361,560 and 17,130,810 shares issued and outstanding (excluding 166,138,440 155,369,190 shares subject to possible redemption), actual and adjusted, respectively		636			1,077			1,713
Class B ordinary shares, $0.0001 par value; 80,000,000 shares authorized; 43,125,000 shares issued and outstanding		4,312			—			4,312
Additional paid-in capital		5,000,059			13,336,770			18,336,829
Accumulated deficit		(5,000	)		(13,337,847	)		(13,342,847	)
Total shareholders’ equity		5,000,007			—			5,000,007
Total liabilities and shareholders’ equity	$	1,728,000,000		$	—		$	1,728,000,000